{"id":62140,"date":"2025-11-04T19:03:02","date_gmt":"2025-11-04T18:03:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/"},"modified":"2025-11-04T19:03:02","modified_gmt":"2025-11-04T18:03:02","slug":"dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/","title":{"rendered":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>\u2013 Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio\u2019s Outstanding Innovation, Impact, and Scientific Excellence \u2013<\/i>\n<\/p>\n<p>SAN CARLOS, Calif.&#8211;(BUSINESS WIRE)&#8211;Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for \u201cBest Startup\u201d by the Galien Foundation.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/5\/Dren_Bio_Logo_JPG_Format.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/5\/Dren_Bio_Logo_JPG_Format.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/21\/Dren_Bio_Logo_JPG_Format.jpg\"><\/a><\/p>\n<p>\nThe Prix Galien USA Awards honor excellence in leading-edge scientific innovation and are widely regarded as the most prestigious distinction in biopharmaceutical research and development. The 2025 award recognizes Dren Bio\u2019s pioneering work in harnessing the body\u2019s immune mechanisms to precisely and safely eliminate pathogenic cells.\n<\/p>\n<p>\nDren Bio\u2019s wholly owned technologies, including its autoreactive T-cell depleter (DR-01) and proprietary Targeted Myeloid Engager and Phagocytosis platform, embody novel, highly differentiated approaches to selectively deplete disease-causing agents. Together, they exemplify the company\u2019s mission to translate cutting-edge immunobiology into transformative therapies for cancer and autoimmune diseases.\n<\/p>\n<p>\nThe Prix Galien USA judging committee brings together some of the most respected and accomplished figures in global biopharma, including:\n<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nKenneth C. Frazier (<i>Committee Chair, Former Chairman &amp; CEO Merck<\/i>)\n<\/li>\n<li>\nRoch Doliveux (<i>Honorary CEO, UCB<\/i>)\n<\/li>\n<li>\nDr. Mikael Dolsten (<i>Former CSO &amp; President, Pfizer Research and Development<\/i>)\n<\/li>\n<li>\nAlex Gorsky (<i>Former CEO &amp; Executive Chairman, Johnson &amp; Johnson<\/i>)\n<\/li>\n<li>\nPenny Heaton (<i>Global Therapeutic Area Head, Vaccines, Janssen<\/i>)\n<\/li>\n<li>\nSheri McCoy (<i>Board of Directors, AstraZeneca; Former CEO, Avon<\/i>)\n<\/li>\n<li>\nJoel S. Marcus (<i>Executive Chairman &amp; Founder, Alexandria<\/i>)\n<\/li>\n<li>\nElias Zerhouni (<i>Former Head of Global R&amp;D, Sanofi<\/i>)\n<\/li>\n<\/ul>\n<p>\n\u201cWe\u2019re deeply honored by this recognition from such an esteemed jury,\u201d said Nenad Tomasevic, Ph.D., Chief Executive Officer and Founder of Dren Bio. \u201cIt reflects the strength of our science, the dedication of our team, and the potential of our programs to address high unmet need in both oncology and autoimmune diseases through a truly differentiated approach.\u201d\n<\/p>\n<p>\nDren Bio\u2019s pioneering science and swift progress also earned praise from leading immunology experts who have collaborated with the company since its inception.\n<\/p>\n<p>\n\u201cI\u2019ve been continually impressed by Dren Bio\u2019s scientific rigor and productivity,\u201d said Lewis Lanier, Ph.D., University of California, San Francisco. \u201cIn just a few short years, the team has made remarkable strides in transforming outcomes for patients lacking effective therapies through a first-in-class approach that selectively depletes autoreactive cells \u2014 an extraordinary achievement.\u201d\n<\/p>\n<p>\n\u201cDren Bio\u2019s work exemplifies the kind of smart, creative and transformative science that the Prix Galien Award was created to celebrate,\u201d said Miriam Merad, M.D., Ph.D., Icahn School of Medicine at Mount Sinai. \u201cAmong the many emerging myeloid-targeting strategies, their Targeted Myeloid Engager and Phagocytosis Platform is one of the most exciting developments in the field today.\u201d\n<\/p>\n<p>\n<b>About Dren Bio<\/b>\n<\/p>\n<p>\nDren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class therapeutics for cancer, autoimmune, and other serious diseases. Its lead candidate, DR-01, is being evaluated in multiple oncology and autoimmune indications. Dren Bio\u2019s proprietary Targeted Myeloid Engager and Phagocytosis Platform is a multispecific antibody-based technology designed to induce potent depletion of disease-causing agents by engaging a novel phagocytic receptor selectively expressed on myeloid cells. The platform\u2019s lead program, DR-0201 (now known as SAR448501), was acquired by Sanofi in May 2025. Its second platform candidate, DR-0202, advanced into first-in-human clinical studies in patients with solid tumors in Q2 2025. In addition, Dren Bio has built an extensive preclinical pipeline including additional multispecific programs generated from its platform, targeting indications in oncology, immunology, and neurology. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.drenbio.com&amp;esheet=54351959&amp;newsitemid=20251104340462&amp;lan=en-US&amp;anchor=www.drenbio.com&amp;index=1&amp;md5=6cdeed5333cbaa9134a79ff2c91e252a\" rel=\"nofollow\" shape=\"rect\">www.drenbio.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Company Contact:<\/b><br \/>Jeff Macfarland<br \/>\n<br \/>EVP, Finance<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x69;r&#x40;&#100;&#x72;&#101;n&#x62;&#105;&#x6f;&#46;c&#x6f;m\" rel=\"nofollow\" shape=\"rect\">ir&#64;drenb&#105;&#111;&#46;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2013 Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio\u2019s Outstanding Innovation, Impact, and Scientific Excellence \u2013 SAN CARLOS, Calif.&#8211;(BUSINESS WIRE)&#8211;Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for \u201cBest Startup\u201d by &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62140","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u2013 Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio\u2019s Outstanding Innovation, Impact, and Scientific Excellence \u2013 SAN CARLOS, Calif.&#8211;(BUSINESS WIRE)&#8211;Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for \u201cBest Startup\u201d by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T18:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup\",\"datePublished\":\"2025-11-04T18:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/\"},\"wordCount\":607,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251104340462\\\/en\\\/2632123\\\/22\\\/Dren_Bio_Logo_JPG_Format.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/\",\"name\":\"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251104340462\\\/en\\\/2632123\\\/22\\\/Dren_Bio_Logo_JPG_Format.jpg\",\"datePublished\":\"2025-11-04T18:03:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251104340462\\\/en\\\/2632123\\\/22\\\/Dren_Bio_Logo_JPG_Format.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251104340462\\\/en\\\/2632123\\\/22\\\/Dren_Bio_Logo_JPG_Format.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/","og_locale":"en_US","og_type":"article","og_title":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend","og_description":"\u2013 Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio\u2019s Outstanding Innovation, Impact, and Scientific Excellence \u2013 SAN CARLOS, Calif.&#8211;(BUSINESS WIRE)&#8211;Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for \u201cBest Startup\u201d by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-04T18:03:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup","datePublished":"2025-11-04T18:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/"},"wordCount":607,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/","url":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/","name":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg","datePublished":"2025-11-04T18:03:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251104340462\/en\/2632123\/22\/Dren_Bio_Logo_JPG_Format.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dren-bio-receives-prestigious-2025-prix-galien-usa-award-for-best-biotech-startup\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62140"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62140\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}